Jin Rong Jie·2025-08-04 07:38Core Points - The China Securities Hong Kong 100 Pharmaceutical and Health Index (H100 Pharmaceutical, L11185) reported a significant increase, with a 20.90% rise over the past month, 36.74% over the past three months, and an impressive 88.77% year-to-date [1] Group 1 - The index is classified according to the China Securities industry classification standards, with all securities in each industry forming the corresponding industry index sample [1] - The base date for the index is December 31, 2004, with a base point of 1000.0 [1] - The index is fully composed of stocks listed on the Hong Kong Stock Exchange, with a 100.00% allocation [1] Group 2 - The composition of the H100 Pharmaceutical Index includes 54.55% in chemical drugs, 19.02% in biological drugs, 15.26% in pharmaceutical and biotechnology services, and 11.18% in medical commerce and services [1] - The index sample is adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December [2] - Weight factors are generally fixed until the next scheduled adjustment, with special circumstances allowing for temporary adjustments [2]